Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Part of paid clinical trials in Buffalo, New York.

Sponsor
Jacobs institute
Study ID
NCT06793059
Status
Recruiting
Apply to this trial

Conditions

  • Aneurysm

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SHIELD — DEVICE
    Pipeline SHIELD device under study

Study Details

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Key Dates

Start date
Jan 1, 2025
Status verified
Mar 2026
Primary completion
Jan 1, 2027
Completion
Jan 1, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: SHIELD Study Arm
    Active treatment with the Pipeline SHIELD Device

Primary Outcome Measure

Occurrence of thromboembolic event(s) [ Time Frame: 12 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Jacobs InstituteBuffaloNew York14203-

Find similar trials in Buffalo, NY

By research site
Jacobs Institute· Buffalo, NY

Related Studies